Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors

Ryan P. Wurz, Liping H. Pettus, Kate Ashton, James Brown, Jian Jeffrey Chen, Brad Herberich, Fang Tsao Hong, Essa Hu-Harrington, Tom Nguyen, David J. St. Jean, Seifu Tadesse, David Bauer, Michele Kubryk, Jinghui Zhan, Keegan Cooke, Petia Mitchell, Kristin L. Andrews, Faye Hsieh, Dean Hickman, Nataraj KalyanaramanTian Wu, Darren L. Reid, Edward K. Lobenhofer, Dina A. Andrews, Nancy Everds, Roberto Guzman, Andrew T. Parsons, Simon J. Hedley, Jason Tedrow, Oliver R. Thiel, Matthew Potter, Robert Radinsky, Pedro J. Beltran, Andrew S. Tasker

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds